Neuro-Oncology Reviews
Volume
27 Number 5
20 February
2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 5, 20 February
Zhong R, He H, Wang X.
Novel
neutrophil targeting platforms in treating Glioblastoma: Latest
evidence and therapeutic approaches.
Int
Immunopharmacol. 2025 Feb 11;150:114173. doi:
10.1016/j.intimp.2025.114173. PMID:
39938169. Review˰ ˍ
Keshari R, Dewani M, Kaur N, Patel GK, Singh SK, Chandra P, Prasad
R, Srivastava R.
Lipid Nanocarriers as
Precision Delivery Systems for Brain Tumors.
Bioconjug
Chem. 2025 Feb 12. doi:
10.1021/acs.bioconjchem.5c00007. PMID:
39937652. Review˰ ˍ
Shi T, Kujawa A, Linares C, Vercauteren T, Booth TC.
Automated
longitudinal treatment response assessment of brain tumors: a
systematic review.
Neuro
Oncol. 2025 Feb 12:noaf037. doi:
10.1093/neuonc/noaf037. PMID:
39935398. Review. ˍ
Thomas S, Morley E, Ritzmann T, Clayton C, Powers K, Airdrie J,
Robinson L, Fifield K, Packham A, Oprandi MC, Lui JF, Whitfield G,
Thorp N, Limond J, Grundy R.
Cognitive
Outcomes in Children Treated for Ependymoma Diagnosed Under 36
Months: A Systematic Review.
Pediatr
Blood Cancer. 2025 Feb 12:e31588. doi:
10.1002/pbc.31588. PMID:
39937086. Review˰ ˍ
Guo X, Piao H, Sui R.
Exosomes in the
Chemoresistance of Glioma: Key Point in Chemoresistance.
J
Cell Mol Med. 2025 Feb 14;29(4):e70401. doi:
10.1111/jcmm.70401. PMID:
39950738. Review. ˍ
Kiang KM, Wong YKH, Sengupta S, Roussel MF, Lu QR.
Developmental
Origins and Oncogenesis in Medulloblastoma.
Annu
Rev Neurosci. 2025 Feb 14. doi:
10.1146/annurev-neuro-112723-061540. PMID:
39952636. Review˰ ˍ
Long Z, Yi Z, Yan W, Wang H.
Trends in
the immunotherapy for glioblastoma: A two-decade bibliometric
analysis.
Hum
Vaccin Immunother. 2025 Feb 14;21(1):2466299. doi:
10.1080/21645515.2025.2466299. PMID:
39950580. Bibliometric analysis. ˍ
Vollmuth P, Karschnia P, Sahm F, Park YW, Ahn SS, Jain R.
A
Radiologist's Guide to IDH-Wildtype Glioblastoma for Efficient
Communication With Clinicians: Part I-Essential Information on
Preoperative and Immediate Postoperative Imaging.
Korean
J Radiol. 2025 Feb 14;26(3):246-268. doi:
10.3348/kjr.2024.0982. PMID:
39999966. Guidelines. ˍ
Mohammadzadeh I, Hajikarimloo B, Niroomand B, Eini P, Ghanbarnia
R, Habibi MA, Albakr A, Borghei-Razavi H.
Application
of artificial intelligence in forecasting survival in high-grade
glioma: systematic review and meta-analysis involving 79,638
participants.
Neurosurg
Rev. 2025 Feb 15;48(1):240. doi:
10.1007/s10143-025-03419-y. PMID:
39954167. Review; Meta-analysis˰
ˍ
Stupak EV, Glotov VM, Askandaryan AS, Clancy SE, Hiana JC,
Cherkasova OP, Stupak VV.
Raman
Spectroscopy in the Diagnosis of Brain Gliomas: A Literature
Review.
Cureus.
2025 Feb 17;17(2):e79165. doi:
10.7759/cureus.79165. PMID:
40109807. Review. ˍ
Basheer HA, Salman NM, Abdullah RM, Elsalem L, Afarinkia K.
Metformin and glioma: Targeting
metabolic dysregulation for enhanced therapeutic outcomes.
Transl
Oncol. 2025 Feb 18;53:102323. doi:
10.1016/j.tranon.2025.102323. PMID:
39970627. Review. ˍ
Tanti MJ, Nevitt S, Yeo M, Bolton W, Chumas P, Mathew R, Maguire
MJ.
Oedema as a prognostic factor for
seizures in meningioma - a systematic review and meta-analysis.
Neurosurg
Rev. 2025 Feb 19;48(1):249. doi:
10.1007/s10143-025-03416-1. PMID:
39969698. Review; Meta-analysis. ˍ
Kiss-Miki R, Obeidat M, Máté V, Teutsch B, Agócs
G, Kiss-Dala S, Hegyi P, Kovács J, Párniczky A,
Tuboly E, Garami M.
Proton or photon?
Comparison of survival and toxicity of two radiotherapy modalities
among pediatric brain cancer patients: A systematic review and
meta-analysis.
PLoS
One. 2025 Feb 20;20(2):e0318194. doi:
10.1371/journal.pone.0318194. PMID:
39977417. Review; Meta-analysis. ˍ